RIL
TRML

Rothschild Investment LLC’s Tourmaline Bio TRML Stock Holding History

Rothschild Investment LLC’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-45
Closed -$2.15K – 3498
2025
Q3 		$2.15K Sell
45
-15
-25% -$416 ﹤0.01% 2183
2025
Q2 		$959 Buy
60
+40
+200% +$648 ﹤0.01% 2496
2025
Q1 		$304 Sell
20
-5
-20% -$80 ﹤0.01% 2760
2024
Q4 		$507 Buy
+25
New +$630 ﹤0.01% 2529

Rothschild Investment LLC's TRML Position: Q4 2025 in Review

Rothschild Investment LLC sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 45 shares — an estimated $2.15K sold.

Rothschild Investment LLC first reported a position in TRML in Q4 2024 and held it in 4 quarters. The position peaked at $2.15K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

  • Rothschild Investment LLC reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
  • Rothschild Investment LLC sold 45 Tourmaline Bio shares in Q4 2025, an estimated $2.15K.
  • Rothschild Investment LLC first reported a position in Tourmaline Bio in Q4 2024 and held it in 4 quarters.
  • Rothschild Investment LLC's Tourmaline Bio position peaked at $2.15K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Rothschild Investment LLC's 13F filing for Q4 2025, filed 10 Feb 2026.